The HudsonAlpha Clinical Services Laboratory (CSL) leverages front-line genomic tools to provide high quality clinical sequencing services to global academic institutions as well as commercial clients. In collaboration with the Genomic Services Laboratory at the HudsonAlpha Institute for Biotechnology, our laboratory specialists have completed more than 2,500 projects and sequenced 130,000+ samples. Data produced on our sequencers have revealed the genetic causes of many inherited diseases. Moreover, sequencing data are contributing to the understanding of complex disorders such as autism, ALS, bipolar disorder, schizophrenia, diabetes and other diseases.
The CSL operates more than 20 Illumina sequencing instruments, including the Illumina HiSeq X platforms that provide the capacity to sequence more than 15,000 human genomes per year. The HiSeq X platform is the first in the nation to be CAP accredited and CLIA certified.
Our role with the UDN is to help diagnose rare unknown diseases for patients who have been on extensive diagnostic odysseys by providing high quality genomic sequencing data that is then interpreted by an experienced, expert team. Diagnostic information and sequencing data are then returned to investigators/clinicians on the project to share with patient families.
HudsonAlpha diagnoses child with extremely rare disorder
September 17, 2015
HudsonAlpha to provide sequencing services to NIH Undiagnosed Diseases Network
September 16, 2015
HudsonAlpha Press Release
New HudsonAlpha clinic will use genetic sequencing to diagnose rare diseases
September 15, 2015
Center for Personal Genomics established
May 1, 2015
Howard Jacob to Join HudsonAlpha
April 7, 2015